Arthur F Ryan Regeneron Pharmaceuticals, Inc. (REGN) insider trading activity

Arthur F Ryan is Director of REGENERON PHARMACEUTICALS, INC.. Currently has a direct ownership of 17,682 shares of REGN, which is worth approximately $20 Million. The most recent transaction as insider was on Sep 03, 2024, when has been sold 100 shares (Common Stock) at a price of $1179.76 per share, resulting in proceeds of $117,976. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 17.7K

1.67% 3M change

5.18% 12M change

Total Value Held $20 Million

ARTHUR F RYAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 03 2024	SELL Open market or private sale	$117,976 $1179.76 p/Share	100 Reduced 0.56%	17,682 Common Stock
Aug 01 2024	SELL Open market or private sale	$107,095 $1081.77 p/Share	99 Reduced 0.55%	17,783 Common Stock
Aug 01 2024	SELL Open market or private sale	$1,100 $1100.03 p/Share	1 Reduced 0.01%	17,782 Common Stock
Jul 01 2024	SELL Open market or private sale	$105,906 $1059.06 p/Share	100 Reduced 0.56%	17,882 Common Stock
Jun 03 2024	SELL Open market or private sale	$99,102 $991.02 p/Share	100 Reduced 0.55%	17,982 Common Stock
May 01 2024	SELL Open market or private sale	$90,147 $901.47 p/Share	100 Reduced 0.55%	18,082 Common Stock
Apr 01 2024	SELL Open market or private sale	$96,156 $961.56 p/Share	100 Reduced 0.55%	18,182 Common Stock
Mar 01 2024	SELL Open market or private sale	$97,823 $978.23 p/Share	100 Reduced 0.54%	18,282 Common Stock
Feb 01 2024	SELL Open market or private sale	$95,251 $952.51 p/Share	100 Reduced 0.54%	18,382 Common Stock
Jan 02 2024	SELL Open market or private sale	$89,569 $895.69 p/Share	100 Reduced 0.54%	18,347 Common Stock
Jan 02 2024	BUY Grant, award, or other acquisition	-	135 Added 0.73%	18,482 Common Stock
Dec 01 2023	SELL Open market or private sale	$81,855 $818.55 p/Share	100 Reduced 0.54%	18,447 Common Stock
Nov 07 2023	SELL Open market or private sale	$82,890 $828.9 p/Share	100 Reduced 0.54%	18,547 Common Stock
Aug 01 2023	SELL Open market or private sale	$73,775 $737.75 p/Share	100 Reduced 0.53%	18,647 Common Stock
Jul 03 2023	SELL Open market or private sale	$71,583 $715.83 p/Share	100 Reduced 0.53%	18,747 Common Stock
Jun 01 2023	SELL Open market or private sale	$73,444 $734.44 p/Share	100 Reduced 0.53%	18,847 Common Stock
May 01 2023	SELL Open market or private sale	$80,546 $805.46 p/Share	100 Reduced 0.53%	18,947 Common Stock
Apr 03 2023	SELL Open market or private sale	$81,999 $819.99 p/Share	100 Reduced 0.52%	19,047 Common Stock
Mar 01 2023	SELL Open market or private sale	$76,244 $762.44 p/Share	100 Reduced 0.52%	19,147 Common Stock
Feb 01 2023	SELL Open market or private sale	$75,746 $757.46 p/Share	100 Reduced 0.52%	19,247 Common Stock
Jan 03 2023	SELL Open market or private sale	$72,700 $727.0 p/Share	100 Reduced 0.52%	19,182 Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	165 Added 0.85%	19,347 Common Stock
Dec 01 2022	SELL Open market or private sale	$75,998 $759.98 p/Share	100 Reduced 0.52%	19,282 Common Stock
Nov 01 2022	SELL Open market or private sale	$75,592 $755.92 p/Share	100 Reduced 0.51%	19,382 Common Stock
Oct 03 2022	SELL Open market or private sale	$72,163 $721.63 p/Share	100 Reduced 0.51%	19,482 Common Stock

Also insider at

CFG

CITIZENS FINANCIAL GROUP INC Financial Services

Director

AFR

Arthur F Ryan

Director

Tarrytown, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells REGN shares.

Notify only if

Value

Insider Trading

Get notified when an Regeneron Pharmaceuticals, Inc. insider buys or sells REGN shares.

Notify only if

Operation

Value

Type

News

Receive news related to REGENERON PHARMACEUTICALS, INC.

Track Activities on REGN

Account